Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Clinical trial NCT01340833 · COMPLETED
Trial details
- NCT number
- NCT01340833
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-08
- Primary completion
- 2011-09-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.